The result of such price controls, of course, has been to squelch innovation, and that’s exactly what has happened.   And yet for decades now, foreign countries have had an ace in the hole: The US, which does not have price controls, has continued to innovate, and US drug companies have charged high prices within the domestic market as a result.    In fact, it’s hard to blame them for charging high, because their costs are  high: 